Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Rascol

Showing results (11-20 of 143) with videos related to

Pageof 15
Sort By:
Pathologie-Biologie|March 1, 1987
[Immunogenetics of multiple sclerosis]M Clanet, A Cambon-Thomsen, A Rascol
Neurology|November 1, 1985
Parkinson's disease and hypertension: chronic bromocriptine treatmentJ L Montastruc, B Chamontin, A Rascol
La Revue Du Praticien|March 9, 1989
[Antiparkinsonian drugs]A Rascol, J L Montastruc, O Rascol
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|February 1, 1984
Should dopamine agonists be given early or late in the treatment of Parkinson's disease?A Rascol, J L Montastruc, O Rascol
Headache|September 1, 1985
Does the piribedil test permit predicting the efficacy of domperidone, a dopaminergic antagonist, in the treatment of migraine?J L Montastruc, J David, A Rascol
La Nouvelle Presse Medicale|September 20, 1980
[On the potentiation of the effects of phenobarbital by dipropylacetic acid (author's transl)]J L Montastruc, J Cotonat, A Rascol
Archives Des Maladies Du Coeur Et Des Vaisseaux|June 1, 1981
[Hypotensive action of a dopaminergic agonist, bromocriptine, in the dog]J L Montastruc, A Rascol, P Montastruc
Archives Des Maladies Du Coeur Et Des Vaisseaux|October 1, 1984
[How do we explain the antihypertensive effect of bromocriptine? Clinical and experimental contribution]B Chamontin, J L Montastruc, A Rascol
Revue Neurologique|January 1, 1990
[Comparison of bromocriptine and levodopa as first line treatment of Parkinson's disease: results of a 3-year prospective randomized study]J L Montastruc, O Rascol, A Rascol
Journal of Neurology, Neurosurgery, and Psychiatry|June 1, 1989
A randomised controlled study of bromocriptine versus levodopa in previously untreated Parkinsonian patients: a 3 year follow-upJ L Montastruc, O Rascol, A Rascol
Pageof 15

Showing results (11-20 of 143) with videos related to

Sort By:
Pageof 15
Pathologie-Biologie|March 1, 1987
[Immunogenetics of multiple sclerosis]M Clanet, A Cambon-Thomsen, A Rascol
Neurology|November 1, 1985
Parkinson's disease and hypertension: chronic bromocriptine treatmentJ L Montastruc, B Chamontin, A Rascol
La Revue Du Praticien|March 9, 1989
[Antiparkinsonian drugs]A Rascol, J L Montastruc, O Rascol
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|February 1, 1984
Should dopamine agonists be given early or late in the treatment of Parkinson's disease?A Rascol, J L Montastruc, O Rascol
Headache|September 1, 1985
Does the piribedil test permit predicting the efficacy of domperidone, a dopaminergic antagonist, in the treatment of migraine?J L Montastruc, J David, A Rascol
La Nouvelle Presse Medicale|September 20, 1980
[On the potentiation of the effects of phenobarbital by dipropylacetic acid (author's transl)]J L Montastruc, J Cotonat, A Rascol
Archives Des Maladies Du Coeur Et Des Vaisseaux|June 1, 1981
[Hypotensive action of a dopaminergic agonist, bromocriptine, in the dog]J L Montastruc, A Rascol, P Montastruc
Archives Des Maladies Du Coeur Et Des Vaisseaux|October 1, 1984
[How do we explain the antihypertensive effect of bromocriptine? Clinical and experimental contribution]B Chamontin, J L Montastruc, A Rascol
Revue Neurologique|January 1, 1990
[Comparison of bromocriptine and levodopa as first line treatment of Parkinson's disease: results of a 3-year prospective randomized study]J L Montastruc, O Rascol, A Rascol
Journal of Neurology, Neurosurgery, and Psychiatry|June 1, 1989
A randomised controlled study of bromocriptine versus levodopa in previously untreated Parkinsonian patients: a 3 year follow-upJ L Montastruc, O Rascol, A Rascol
Pageof 15